Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Accumulation of neurotoxic soluble amyloid-beta protein (Aβ) oligomers in the brains of patients with Alzheimer disease (AD) and their role in AD pathogenesis have emerged as topics of considerable interest in recent years. Soluble Aβ oligomers impair synaptic and neuronal function, leading to neurodegeneration that is clinically manifested by memory and cognitive dysfunction. The precise mechanisms whereby Aβ oligomers cause neurotoxicity remain unknown. Emerging insights into the mechanistic link between neuronal receptors and soluble Aβ oligomers highlight the potential role of these receptors in Aβ-mediated neurotoxicity in AD. The current review focuses on studies describing interactions between soluble Aβ oligomers and neuronal receptors, and their role in AD pathogenesis. Furthermore, these studies provide insight into potential therapies for AD using compounds directed at putative target receptors for the action of Aβ in the central nervous system. We focus on interactions of Aβ with subtypes of acetylcholine and glutamatergic receptors. Additionally, neuronal receptors such as insulin, amylin and receptor for advanced glycation end products could be potential targets for soluble Aβ-oligomer-mediated neurotoxicity. Aβ interactions with other receptors such as the p75 neurotrophin receptors, which are highly expressed on cholinergic basal forebrain neurons lost in AD, are also highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of these receptors leads to changes in LTP, modulation of various signaling cascades, including Jun kinase, p38, MAPKs and p53, as well as caspase activation (reviewed in [42]), some of which can cause apoptosis and cell death.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedRAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · cited 1×
“Pathology 178, 140-149 139 Bierhaus, A. et al. (2005) Understanding RAGE, the”
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Research works printed but not linked: 137
- 10.1523/JNEUROSCI.2338-05.2005 · DOI · Paper page
- 10.1046/j.1471-4159.2000.0751155.x · DOI · Paper page
- 10.1016/S0014-2999(98)00487-7 · DOI
- 10.1073/pnas.89.21.10075 · DOI · Paper page
- 10.1016/j.euroneuro.2010.06.003 · DOI · Paper page
- 10.1016/j.ejphar.2004.02.049 · DOI · Paper page
- 10.3233/JAD-2010-1288 · DOI · Paper page
- 10.1523/JNEUROSCI.3034-05.2005 · DOI · Paper page
- 10.2174/092986706777442011 · DOI · Paper page
- Zieminska, 2006, Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors, Acta Neurobiologiae Experimentalis, 66, 301, 10.55782/ane-2006-1619 · DOI
- 10.1523/JNEUROSCI.5980-08.2009 · DOI · Paper page
- 10.1515/rns.2011.029 · DOI · Paper page
- 10.1111/j.1749-6632.1996.tb34401.x · DOI · Paper page
- Wenk, 2003, Neuropathologic changes in Alzheimer's disease, Journal of Clinical Psychiatry, 64, 7
- 10.1523/JNEUROSCI.1074-10.2010 · DOI · Paper page
- 10.2174/138920207783769521 · DOI
- 10.1016/j.neuropharm.2005.05.020 · DOI
- 10.1002/psc.573 · DOI · Paper page
- Lee, 2004, The role of metabotropic glutamate receptors in Alzheimer's disease, Acta Neurobiologiae Experimentalis, 64, 89, 10.55782/ane-2004-1494 · DOI
- 10.1113/jphysiol.2005.103754 · DOI · Paper page
- Xie, 2002, Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor, Journal of Neuroscience, 22, 10.1523/JNEUROSCI.22-10-j0001.2002 · DOI · Paper page
- 10.1523/JNEUROSCI.1843-07.2007 · DOI · Paper page
- 10.1126/science.1074069 · DOI · Paper page
- 10.1016/S1537-1891(02)00198-2 · DOI
- 10.1074/jbc.274.49.34893 · DOI · Paper page
- 10.1523/JNEUROSCI.1850-08.2008 · DOI · Paper page
- 10.1073/pnas.95.11.6448 · DOI · Paper page
- 10.1016/S0306-4522(01)00460-2 · DOI · Paper page
- 10.1523/JNEUROSCI.1051-04.2004 · DOI · Paper page
- 10.1016/j.neurobiolaging.2010.02.014 · DOI · Paper page
- 10.1074/jbc.275.8.5626 · DOI · Paper page
- 10.1038/416535a · DOI · Paper page
- 10.1152/jn.01138.2002 · DOI
- 10.1016/j.neurobiolaging.2010.01.011 · DOI · Paper page
- 10.1038/nrendo.2009.48 · DOI · Paper page
- Levey, 1991, Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies, Journal of Neuroscience, 11, 3218, 10.1523/JNEUROSCI.11-10-03218.1991 · DOI · Paper page
- 10.1523/JNEUROSCI.0157-10.2010 · DOI · Paper page
- 10.1001/archneurol.2011.69 · DOI · Paper page
- 10.1016/j.neurobiolaging.2005.06.015 · DOI · Paper page
- 10.1073/pnas.95.11.6448 · DOI · Paper page
- 10.1124/pr.108.000562 · DOI · Paper page
- 10.1523/JNEUROSCI.6159-08.2009 · DOI · Paper page
- 10.1002/hipo.10107 · DOI · Paper page
- 10.1098/rstb.2006.1858 · DOI · Paper page
- 10.1073/pnas.1013543107 · DOI · Paper page
- 10.1046/j.1471-4159.2003.02296.x · DOI · Paper page
- Farber, 1995, Regulated secretion of beta-amyloid precursor protein in rat brain, Journal of Neuroscience, 15, 7442, 10.1523/JNEUROSCI.15-11-07442.1995 · DOI · Paper page
- Thathiah, 2011, The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nature Reviews, Neuroscience, 12, 73
- 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- 10.1016/j.ceca.2011.02.001 · DOI · Paper page
- 10.1152/physrev.00014.2003 · DOI · Paper page
- 10.2174/138161206775474224 · DOI · Paper page
- 10.1038/nm1782 · DOI · Paper page
- 10.1016/j.ajpath.2010.11.022 · DOI
- 10.1074/jbc.M111.241299 · DOI
- 10.1002/hipo.20214 · DOI · Paper page
- 10.1016/S0006-291X(02)00429-1 · DOI
- 10.1073/pnas.0901533106 · DOI
- 10.1002/syn.20951 · DOI · Paper page
- 10.1016/S0166-2236(00)01656-8 · DOI · Paper page
- 10.1586/ern.09.24 · DOI · Paper page
- 10.1046/j.1471-4159.1995.64041888.x · DOI · Paper page
- 10.1016/0896-6273(93)90306-C · DOI · Paper page
- 10.1016/j.pneurobio.2007.02.001 · DOI · Paper page
- 10.1016/S0028-3908(00)00079-4 · DOI
- 10.1016/j.expneurol.2006.09.028 · DOI · Paper page
- 10.1016/S0301-0082(99)00006-4 · DOI · Paper page
- 10.1073/pnas.93.24.13541 · DOI · Paper page
- Jia, 1998, Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5, Learning and Memory, 5, 331, 10.1101/lm.5.4.331 · DOI · Paper page
- 10.1159/000102568 · DOI · Paper page
- 10.1196/annals.1254.007 · DOI · Paper page
- 10.1002/ana.410300410 · DOI · Paper page
- 10.3233/JAD-2009-1030 · DOI · Paper page
- Derkach, 2007, Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nature Reviews, Neuroscience, 8, 101
- 10.1016/j.expneurol.2006.01.018 · DOI · Paper page
- 10.1164/rccm.200707-1069OC · DOI
- Pettit, 2001, beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice, Journal of Neuroscience, 21, 10.1523/JNEUROSCI.21-01-j0003.2001 · DOI · Paper page
- Schmidt, 2009, The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease, Current Opinion in Investigational Drugs, 10, 672
- 10.1016/j.neurobiolaging.2005.07.010 · DOI
- 10.1038/nrd2896 · DOI · Paper page
- 10.1046/j.1471-4159.1994.63030815.x · DOI · Paper page
- 10.1002/jnr.21998 · DOI · Paper page
- 10.1016/j.nurt.2008.05.002 · DOI
- 10.1523/JNEUROSCI.2909-05.2005 · DOI · Paper page
- 10.1523/JNEUROSCI.3952-08.2009 · DOI · Paper page
- 10.1016/0304-3940(93)90103-R · DOI
- 10.1523/JNEUROSCI.6393-09.2010 · DOI · Paper page
- 10.1111/j.1471-4159.2006.04444.x · DOI · Paper page
- 10.1016/S0303-7207(01)00455-5 · DOI · Paper page
- 10.1074/jbc.M200066200 · DOI · Paper page
- 10.1002/neu.10203 · DOI · Paper page
- 10.1038/nn992 · DOI · Paper page
- 10.1002/pmic.200900651 · DOI · Paper page
- 10.1007/s10059-011-0030-x · DOI · Paper page
- 10.1523/JNEUROSCI.2733-10.2011 · DOI · Paper page
- 10.1038/35050116 · DOI · Paper page
- 10.1016/S0304-3940(96)12462-9 · DOI · Paper page
- Chen, 2007, RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease, Current Molecular Medicine, 7, 735, 10.2174/156652407783220741 · DOI · Paper page
- 10.1038/nature01176 · DOI · Paper page
- 10.1006/exnr.2002.8018 · DOI
- 10.2174/156720508785908937 · DOI · Paper page
- 10.1523/JNEUROSCI.0204-08.2008 · DOI · Paper page
- 10.1093/jnen/64.4.263 · DOI · Paper page
- 10.1172/JCI119772 · DOI · Paper page
- 10.1016/0092-8674(92)90413-7 · DOI · Paper page
- 10.1073/pnas.90.22.10573 · DOI · Paper page
- 10.1152/ajpregu.00703.2009 · DOI · Paper page
- 10.1111/j.1471-4159.2006.03764.x · DOI · Paper page
- 10.1111/j.1471-4159.1993.tb07480.x · DOI · Paper page
- 10.1016/j.neurobiolaging.2005.01.004 · DOI · Paper page
- 10.1126/science.1072994 · DOI · Paper page
- 10.1001/archneur.62.11.1734 · DOI · Paper page
- 10.1016/0092-8674(91)90540-F · DOI · Paper page
- 10.1006/exnr.2001.7710 · DOI
- 10.1046/j.1471-4159.1998.71020506.x · DOI · Paper page
- 10.1016/j.febslet.2008.05.006 · DOI · Paper page
- 10.1016/j.neuron.2004.04.001 · DOI · Paper page
- 10.1196/annals.1433.026 · DOI · Paper page
- 10.1523/JNEUROSCI.3478-07.2007 · DOI · Paper page
- 10.1096/fj.08-109033 · DOI · Paper page
- 10.1007/BF03160113 · DOI
- 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
- 10.1111/j.1471-4159.2006.03905.x · DOI · Paper page
- 10.1016/j.ceca.2009.12.010 · DOI · Paper page
- 10.1084/jem.20011797 · DOI · Paper page
- 10.1038/labinvest.3780116 · DOI · Paper page
- 10.1002/cne.10122 · DOI · Paper page
- 10.2174/156720510791050920 · DOI
- 10.1016/S0896-6273(02)00633-5 · DOI · Paper page
- 10.1385/JMN:25:2:141 · DOI
- 10.1016/j.nbd.2006.04.005 · DOI · Paper page
- 10.1016/j.nbd.2005.05.001 · DOI · Paper page
- 10.1073/pnas.081553598 · DOI · Paper page
- 10.1523/JNEUROSCI.0350-08.2008 · DOI · Paper page
- 10.1172/JCI200114002 · DOI
- 10.1073/pnas.91.22.10703 · DOI · Paper page
- 10.1046/j.1471-4159.1999.0731635.x · DOI · Paper page
Cited by
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
“…EphB2, p75 neurotrophin receptor (p75NTR), α7-nicotinic receptor, adrenergic receptors, receptor for advanced glycation end-products (RAGE), calcium channels, and less known components, such as LilRb2, formyl-peptideR2 and FcγRIIb (see Patel and Jhamandas, 2012; Viola and Klein, 2015, for reviews).”
BackgroundSadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294
Zhao, L., Dong, Q., Luo, C., Wu, Y., Bu, D., Qi, X., Luo, Y., & Zhao, Y. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.067 · Cited by 127
“Interestingly, Advanced Glycosylation End-product Receptor (AGER) signaling pathway, helped amyloid-beta peptide (Ab) and mediated Ab neurotoxicity, and promoted Ab influx into the brain [27].”
BackgroundEphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
M. Vargas, L., Leal, N., Estrada, L. D., González, A., Serrano, F., Araya, K., Gysling, K., Inestrosa, N. C., Pasquale, E. B., & Alvarez, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092309 · Cited by 85
Metadata
- Authors
- Patel, A. N., & Jhamandas, J. H.
- Venue
- Expert Reviews in Molecular Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2012-01
- Volume
- 14
- ISSN
- 1462-3994
- Cited by
- 43
- References
- 46
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. https://app.cochat.ai/papers/10.1017/s1462399411002134
- The paper
- Patel, A. N., & Jhamandas, J. H. (2012). Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/s1462399411002134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.